214 related articles for article (PubMed ID: 34485520)
1. High-Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA).
Kui L; Li M; Yang X; Yang L; Kong Q; Pan Y; Xu Z; Wang S; Mo D; Dong Y; Liu Y; Miao J
Biomed Res Int; 2021; 2021():5955343. PubMed ID: 34485520
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput
Kui L; Kong Q; Yang X; Pan Y; Xu Z; Wang S; Chen J; Wei K; Zhou X; Yang X; Wu T; Mastan A; Liu Y; Miao J
Front Oncol; 2021; 11():684351. PubMed ID: 34490085
[TBL] [Abstract][Full Text] [Related]
3. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
5. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
6. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
9. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
[TBL] [Abstract][Full Text] [Related]
12. Mechanism underlying the effect of Liujunzi decoction on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy.
Xin XL; Wang GD; Han R; Jiang Y; Liu C; Liu LS; Xu ZY
J Tradit Chin Med; 2022 Feb; 42(1):108-115. PubMed ID: 35294130
[TBL] [Abstract][Full Text] [Related]
13. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
14. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
17. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
18. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
[TBL] [Abstract][Full Text] [Related]
20. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.
Zhou D; Xie M; He B; Gao Y; Yu Q; He B; Chen Q
Mol Med Rep; 2017 Oct; 16(4):5129-5136. PubMed ID: 28849055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]